These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

654 related articles for article (PubMed ID: 15986018)

  • 1. Diagnosis and treatment of primary glomerular diseases. Membranous nephropathy, focal segmental glomerulosclerosis and IgA nephropathy.
    Deegens JK; Wetzels JF
    Minerva Urol Nefrol; 2005 Sep; 57(3):211-36. PubMed ID: 15986018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic tests and treatment options in glomerular disease: 2014 update.
    Hogan J; Mohan P; Appel GB
    Am J Kidney Dis; 2014 Apr; 63(4):656-66. PubMed ID: 24239051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of sex in primary glomerulonephritis.
    Cattran DC; Reich HN; Beanlands HJ; Miller JA; Scholey JW; Troyanov S;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2247-53. PubMed ID: 18182409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggressive treatment may be needed for idiopathic membranous nephropathy with focal segmental glomerulosclerosis lesions.
    Cheng P; Xie Q; Liu S; Liu X; Wang L; Hao CM
    Rev Assoc Med Bras (1992); 2024; 70(4):e20230871. PubMed ID: 38716932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine treatment of glomerular diseases.
    Klein M; Radhakrishnan J; Appel G
    Annu Rev Med; 1999; 50():1-15. PubMed ID: 10073260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal and Segmental Glomerulosclerosis and Membranous Nephropathy overlapping in a patient with Nephrotic Syndrome: a case report.
    Silva CAD; Custódio FB; Monteiro MLGDR; Araújo SA; Araújo LS; Côrrea RRM; Reis MAD; Machado JR
    J Bras Nefrol; 2020 Mar; 42(1):113-117. PubMed ID: 30806447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil in primary glomerulopathies.
    Sepe V; Libetta C; Giuliano MG; Adamo G; Dal Canton A
    Kidney Int; 2008 Jan; 73(2):154-62. PubMed ID: 17989649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New diagnostic tests and new therapies for glomerular diseases.
    Appel GB; Appel AS
    Blood Purif; 2013; 35(1-3):81-5. PubMed ID: 23343551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy.
    Heeringa SF; Branten AJ; Deegens JK; Steenbergen E; Wetzels JF
    Nephrol Dial Transplant; 2007 Aug; 22(8):2201-7. PubMed ID: 17442739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A; Hill GS; Montseny JJ; Meyrier A
    Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival analysis of Thai patients with IgM nephropathy, focal segmental glomerulosclerosis and membranous nephrotic syndrome.
    Sumethkul V; Sakulsaengprapha A; Chalermsanyakorn P; Indraprasit S
    J Med Assoc Thai; 2000 Mar; 83 Suppl 1():S123-9. PubMed ID: 10865418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus associated glomerulopathies.
    Ozkok A; Yildiz A
    World J Gastroenterol; 2014 Jun; 20(24):7544-54. PubMed ID: 24976695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of resistant glomerular diseases with adrenocorticotropic hormone gel: a prospective trial.
    Bomback AS; Canetta PA; Beck LH; Ayalon R; Radhakrishnan J; Appel GB
    Am J Nephrol; 2012; 36(1):58-67. PubMed ID: 22722778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An adolescent with relapsing nephrotic syndrome: minimal-change disease versus focal-segmental glomerulosclerosis versus C1q nephropathy.
    Shappell SB; Myrthil G; Fogo A
    Am J Kidney Dis; 1997 Jun; 29(6):966-70. PubMed ID: 9186086
    [No Abstract]   [Full Text] [Related]  

  • 15. [Instructions and implementations for percutaneous renal biopsy. Guidelines for the therapy of glomerular nephropaties].
    Cagnoli L;
    G Ital Nefrol; 2003; 20 Suppl 24():S3-47. PubMed ID: 14666502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of idiopathic focal segmental glomerulosclerosis in adults.
    Hogan J; Radhakrishnan J
    Adv Chronic Kidney Dis; 2014 Sep; 21(5):434-41. PubMed ID: 25168833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thin basement membrane nephropathy associated with other glomerular diseases.
    Norby SM; Cosio FG
    Semin Nephrol; 2005 May; 25(3):176-9. PubMed ID: 15880329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study.
    Senthil Nayagam L; Ganguli A; Rathi M; Kohli HS; Gupta KL; Joshi K; Sakhuja V; Jha V
    Nephrol Dial Transplant; 2008 Jun; 23(6):1926-30. PubMed ID: 17989103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrotic Syndrome After Hematopoietic Stem Cell Transplant: Outcomes in Iran.
    Saddadi F; Alidadi A; Hakemi M; Bahar B
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):90-92. PubMed ID: 28260442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired glomerular lesions in patients with Down syndrome.
    Said SM; Cornell LD; Sethi S; Fidler ME; Al Masri O; Marple J; Nasr SH
    Hum Pathol; 2012 Jan; 43(1):81-8. PubMed ID: 21733549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.